ERBB2 and breast carcinoma: Breast cancer disease heterogeneity has been confirmed at the gene expression level and categorized into five molecular subtypes: luminal A, luminal B, HER2+, basal-like, and normal-like, each with distinct gene expression patterns and prognosis [5].